Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma

NCT05106946 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Malignancy

Interventions

BIOLOGICAL: ThisCART22 cells

Sponsor

Fundamenta Therapeutics, Ltd.

Collaborators

[object Object]